General MedicationsINJECTIONGeneric
AKINETON
BIPERIDEN LACTATE
Standard Dose
5MG/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview AKINETON is listed in Drugs@FDA under application 012418 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient BIPERIDEN LACTATE Form and strength INJECTABLE;INJECTION - 5MG/ML Sponsor ABBVIE Submission history Latest submission status date: 2001-07-23 00:00:00.
Structured Monograph
Clinical summary
Approval overview AKINETON is listed in Drugs@FDA under application 012418 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient BIPERIDEN LACTATE Form and strength INJECTABLE;INJECTION - 5MG/ML Sponsor ABBVIE Submission history Latest submission status date: 2001-07-23 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.